Millennium Management
ALXO icon

Millennium Management’s ALX Oncology ALXO Stock Holding History

Millennium Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$113K – 5663
2025
Q4 		$113K Buy
100,000
+59,100
+144% +$89.5K ﹤0.01% 5609
2025
Q3 		$74.8K Buy
+40,900
New +$35.4K ﹤0.01% 5764
2025
Q1 		– Sell
-125,000
Closed -$209K – 5807
2024
Q4 		$209K Buy
+125,000
New +$192K ﹤0.01% 5283
2024
Q3 		– Sell
-130,000
Closed -$784K – 6058
2024
Q2 		$784K Buy
130,000
+100,000
+333% +$1.23M ﹤0.01% 4278
2024
Q1 		$335K Sell
30,000
-11,600
-28% -$163K ﹤0.01% 5063
2023
Q4 		$619K Sell
41,600
-118,800
-74% -$1.13M ﹤0.01% 4515
2023
Q3 		$770K Buy
160,400
+109,900
+218% +$596K ﹤0.01% 4366
2023
Q2 		$379K Buy
+50,500
New +$331K ﹤0.01% 4734
2021
Q2 		– Sell
-9,000
Closed -$664K – 6475
2021
Q1 		$664K Buy
+9,000
New +$708K ﹤0.01% 4582

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Millennium Management's ALXO Position: Q1 2026 in Review

Millennium Management reduced its ALX Oncology (ALXO) stake by 38% in Q1 2026, selling an estimated $2.32M and leaving 1,988,559 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Millennium Management first reported a position in ALXO in Q2 2021 and has held it in 17 quarters since. The position peaked at $7.99M in Q2 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Millennium Management held 1,988,559 shares of ALX Oncology worth $3.99M as of Q1 2026.
  • Millennium Management sold 1,216,060 ALX Oncology shares in Q1 2026, an estimated $2.32M.
  • ALX Oncology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3201 holding.
  • Millennium Management first reported a position in ALX Oncology in Q2 2021 and has held it in 17 quarters since.
  • Millennium Management's ALX Oncology position peaked at $7.99M in Q2 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.